Shah et al. [32], in his study, reported that the low CD4/CD8 ratio was significantly associated with the worse prognosis of patients with cervical carcinoma, and in the study of Chang-Juan Tao, from 2016, it was shown that the value of the higher CD4/CD8 ratio (≥1.77) was associated with the disease-free interval [33]. This evidence concerns the gene CD8A and cervical carcinoma.